Patient#	Sample#	ACTN1:(ACTN1, protein),	ADAM12:(ADAM12, protein),	CCL5:(CCL5, protein),	CXCL12:(CXCL12, protein),	CXCR4:(CXCR4, protein),	DNM2:(DNM2, protein),	F2:(F2, protein),	FGF2:(FGF2, protein),	FGFR1:(FGFR1, protein),	Fibronectin:(Fibronectin, protein),	GIPC1:(GIPC1, protein),	LAMA1:(LAMA1, protein),	Laminin alpha3:(Laminin alpha3, protein),	FZD7:(FZD7, protein),	MDK:(MDK, protein),	MMP9_107-707:(MMP9_107-707, protein),	NUDT16L1:(NUDT16L1, protein),	PKC delta:(PKC delta, protein),	PLG:(PLG, protein),	RHOA:(RHOA, protein),	SDCBP:(SDCBP, protein),	TFPI:(TFPI, protein),	THBS1:(THBS1, protein),	TNFRSF13B:(TNFRSF13B, protein),	Tenascin C:(Tenascin C, protein),	FAK	PAK1	cell adhesion:(PAK1, active),	PRKCA	SDC4:(F2, active),(Fibronectin, active),(MMP9_107-707, active),(PKC delta, active),(PLG, active),(PRKCA, active),(SDC4, protein),	Syndecan-4/ADAM12:(ADAM12, active),(SDC4, active),	Syndecan-4/CXCL12:(CXCL12, active),(SDC4, active),	Syndecan-4/Dynamin:(DNM2, active),(SDC4, active),	Syndecan-4/FZD7:(FZD7, active),(SDC4, active),	Syndecan-4/FGFR1/FGF:(FGF2, active),(FGFR1, active),(SDC4, active),	Syndecan-4/GIPC:(GIPC1, active),(SDC4, active),	Syndecan-4/Laminin alpha3:(Laminin alpha3, active),(SDC4, active),	Syndecan-4/Laminin alpha1:(LAMA1, active),(SDC4, active),	Syndecan-4/Midkine:(MDK, active),(SDC4, active),	Syndecan-4/RANTES:(CCL5, active),(SDC4, active),	Syndecan-4/Syndesmos:(NUDT16L1, active),(SDC4, active),	Syndecan-4/Syntenin:(SDC4, active),(SDCBP, active),	Syndecan-4/TFPI:(SDC4, active),(TFPI, active),	Syndecan-4/TSP1:(SDC4, active),(THBS1, active),	Syndecan-4/Tenascin C:(SDC4, active),(Tenascin C, active),	Syndecan-4/alpha-Actinin:(ACTN1, active),(SDC4, active),	Syndecan-4/CXCL12/CXCR4:(CXCR4, active),(Syndecan-4/CXCL12, active),	Syndecan-4/PI-4-5-P2:(PI-4-5-P2, active),(SDC4, active),	Syndecan-4/TACI:(SDC4, active),(TNFRSF13B, active),	cytoskeleton organization:(Syndecan-4/Syndesmos, active),	integrin-mediated signaling pathway:(Syndecan-4/Tenascin C, active),	cell migration:(SDC4, active),(Syndecan-4/GIPC, active),	positive regulation of cell adhesion:(Syndecan-4/Laminin alpha1, active),(Syndecan-4/Laminin alpha3, active),	positive regulation of focal adhesion formation:(PRKCA, active),(RHOA, active),(Syndecan-4/ADAM12, active),	vasculogenesis:(Syndecan-4/TSP1, active),	Syndecan-4/PI-4-5-P2/PKC alpha:(PRKCA, active),(Syndecan-4/PI-4-5-P2, active),	Syndecan-4/PKC alpha:(PRKCA, active),(Syndecan-4/PI-4-5-P2, active),	positive regulation of JNK cascade:(Syndecan-4/CXCL12/CXCR4, active),	positive regulation of MAPKKK cascade:(Syndecan-4/CXCL12/CXCR4, active),	
